Financial reports
20-F
2023 FY
Annual report (foreign)
10 May 24
NT 20-F
Notice of late annual filing (foreign)
1 May 24
20-F
2022 FY
Annual report (foreign)
28 Apr 23
20-F/A
2021 FY
Annual report (foreign) (amended)
26 Jan 23
20-F
2021 FY
Annual report (foreign)
3 May 22
NT 20-F
Notice of late annual filing (foreign)
3 May 22
Current reports
6-K
Current report (foreign)
12 Jun 24
6-K
XORTX to Present at BIO International Convention 2024
4 Jun 24
6-K
Current report (foreign)
17 May 24
6-K
Condensed Interim Consolidated Financial Statements
16 May 24
6-K
Current report (foreign)
30 Apr 24
6-K
XORTX Announces Publication of Key Research in ADPKD
22 Apr 24
6-K
XORTX Welcomes New Member to the Board of Directors
8 Apr 24
6-K
XORTX Announces Participation in Spring 2024 Investor Conferences
8 Apr 24
6-K
XORTX Announces New Clinical Advisory Board Member
27 Mar 24
6-K
XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial
19 Mar 24
Registration and prospectus
424B3
Prospectus supplement
13 Jun 24
424B3
Prospectus supplement
13 Jun 24
424B3
Prospectus supplement
13 Jun 24
424B3
Prospectus supplement
13 Jun 24
424B3
Prospectus supplement
13 Jun 24
424B3
Prospectus supplement
13 Jun 24
424B3
Prospectus supplement
13 Jun 24
424B3
Prospectus supplement
13 Jun 24
424B3
Prospectus supplement
13 Jun 24
424B3
Prospectus supplement
13 Jun 24
Proxies
No filings
Other
EFFECT
Notice of effectiveness
8 Aug 23
EFFECT
Notice of effectiveness
8 Aug 23
EFFECT
Notice of effectiveness
6 Feb 23
CORRESP
Correspondence with SEC
1 Feb 23
UPLOAD
Letter from SEC
31 Jan 23
EFFECT
Notice of effectiveness
3 Oct 22
EFFECT
Notice of effectiveness
23 Sep 22
CORRESP
Correspondence with SEC
22 Sep 22
CORRESP
Correspondence with SEC
22 Sep 22
CORRESP
Correspondence with SEC
21 Sep 22